August 20, 2024Open Access
Sacubitril-Valsartan in Patients Requiring Hemodialysis
Key Points
Key points are not available for this paper at this time.
Abstract
Randomized clinical trials have shown that sacubitril-valsartan reduces the risks of mortality and hospitalization in patients with heart failure with reduced ejection fraction (HFrEF), but patients with kidney failure requiring dialysis were excluded.
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
D
Dustin Le
Thomas Jefferson University
M
Morgan E. Grams
Boston University
Josef Coresh
Boston University
Journals
JAMA Network Open
Actions
Institutions
Johns Hopkins University
New York University
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...